Comment on the Manuscript “Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Comment on the Manuscript “Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies” ; volume:10 ; number:2 ; year:2021 ; pages:161-162 ; extent:2
Liver cancer ; 10, Heft 2 (2021), 161-162 (gesamt 2)
- Creator
-
Li, Zhaonan
Jiao, Dechao
Han, Xinwei
- DOI
-
10.1159/000513719
- URN
-
urn:nbn:de:101:1-2021042200204615826633
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Zhaonan
- Jiao, Dechao
- Han, Xinwei
Other Objects (12)
Reply to the Letter “Comment on Regarding Manuscript ‘Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies’”
Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies
Curative gene therapies for rare diseases
Johannes Kepler's comments in Jost Bürgi's manuscript on “Coss”
Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China
Die curative Syphilisation
Manuscript.
Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
La methode curative des playes
Curative Treatment of Prostate Cancer
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Ein Manuscript!
Reply to the Letter “Comment on Regarding Manuscript ‘Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies’”
Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies
Curative gene therapies for rare diseases
Johannes Kepler's comments in Jost Bürgi's manuscript on “Coss”
Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China
Die curative Syphilisation
Manuscript.
Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
La methode curative des playes
Curative Treatment of Prostate Cancer
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Ein Manuscript!
Reply to the Letter “Comment on Regarding Manuscript ‘Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies’”
Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies
Curative gene therapies for rare diseases
Johannes Kepler's comments in Jost Bürgi's manuscript on “Coss”
Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China
Die curative Syphilisation
Manuscript.
Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
La methode curative des playes
Curative Treatment of Prostate Cancer
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability